Institutional Ownership Cullinan Oncology, Inc. (CGEM)
This table provides information about the institutional ownership of Cullinan Oncology, Inc. (CGEM). We have compiled data on the 155 institutions that hold shares in the stock, with a total of 68.5 Million shares, which have been reported (via 13F filing form) to have a value of $515 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
May 14, 2025 Q1 2025 |
79,438
shares
|
$644,242
0.0% of portfolio
|
Q1 2025
Added 122.29%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
May 12, 2025 Q1 2025 |
77,621
shares
|
$629,506
0.0% of portfolio
|
Q1 2025
Added 282.88%
|
|
Rhumbline Advisers
Boston, MA |
May 29, 2025 Q1 2025 |
71,338
shares
|
$578,551
0.0% of portfolio
|
Q4 2024
Reduced 4.39%
|
|
Trexquant Investment LP
Stamford, CT |
May 14, 2025 Q1 2025 |
68,467
shares
|
$555,267
0.01% of portfolio
|
Q1 2025
New holding
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
62,700
shares
|
$508,496
0.0% of portfolio
|
Q4 2024
Reduced 14.81%
|
|
Rafferty Asset Management, LLC
New York, NY |
May 14, 2025 Q1 2025 |
54,942
shares
|
$445,579
0.0% of portfolio
|
Q1 2025
Reduced 38.72%
|
|
Intech Investment Management LLC
West Palm Beach, FL |
May 20, 2025 Q1 2025 |
49,878
shares
|
$404,510
0.0% of portfolio
|
Q1 2025
Added 56.94%
|
|
Invesco Ltd.
Atlanta, GA |
May 12, 2025 Q1 2025 |
49,243
shares
|
$399,360
0.0% of portfolio
|
Q1 2025
Reduced 17.31%
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
45,755
shares
|
$371,073
0.0% of portfolio
|
Q1 2024
Added 6.65%
|
|
Xtx Topco LTD
London, X0 |
May 07, 2025 Q1 2025 |
44,493
shares
|
$360,838
0.02% of portfolio
|
Q1 2025
Added 2.52%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
43,547
shares
|
$353,166
0.0% of portfolio
|
Q1 2025
Reduced 78.03%
|
|
Nebula Research & Development LLC
New York, NY |
May 15, 2025 Q1 2025 |
43,407
shares
|
$352,030
0.03% of portfolio
|
Q1 2025
Reduced 0.68%
|
|
Legal & General Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
42,808
shares
|
$347,172
0.0% of portfolio
|
Q4 2023
Reduced 67.27%
|
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
May 15, 2025 Q1 2025 |
40,599
shares
|
$329,257
0.0% of portfolio
|
Q1 2025
Added 175.53%
|
|
Tema Etfs LLC
New York, NY |
May 14, 2025 Q1 2025 |
39,164
shares
|
$317,620
0.09% of portfolio
|
Q1 2025
Added 37.74%
|
|
Neos Investment Management LLC
Westport, CT |
May 15, 2025 Q1 2025 |
39,164
shares
|
$317,620
0.01% of portfolio
|
Q1 2025
Added 37.74%
|
|
Exodus Point Capital Management, LP
New York, NY |
May 14, 2025 Q1 2025 |
35,200
shares
|
$285,472
0.0% of portfolio
|
Q1 2025
Added 49.79%
|
|
Jane Street Group, LLC
New York, NY |
May 19, 2025 Q1 2025 |
34,396
shares
|
$278,951
0.0% of portfolio
|
Q1 2025
Added 135.86%
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
May 15, 2025 Q1 2025 |
33,319
shares
|
$270,217
0.0% of portfolio
|
Q1 2025
Added 1.02%
|
|
Ubs Oconnor LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
32,903
shares
|
$266,843
0.02% of portfolio
|
Q1 2025
Reduced 41.34%
|
|
High Vista Strategies LLC
Boston, MA |
May 15, 2025 Q1 2025 |
31,893
shares
|
$258,652
0.1% of portfolio
|
Q3 2024
New holding
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
31,721
shares
|
$257,257
0.0% of portfolio
|
Q1 2025
Added 7.55%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
31,494
shares
|
$255,416
0.0% of portfolio
|
Q1 2025
Reduced 35.64%
|
|
Met Life Investment Management, LLC
Whippany, NJ |
May 14, 2025 Q1 2025 |
31,454
shares
|
$255,091
0.0% of portfolio
|
Q1 2025
Reduced 1.88%
|
|
California State Teachers Retirement System
West Sacramento, CA |
May 15, 2025 Q1 2025 |
31,251
shares
|
$253,445
0.0% of portfolio
|
Q2 2024
Added 17.3%
|